Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review. IJPHRD [Internet]. 2020 Jul. 30 [cited 2026 Jun. 27];11(7):1063-9. Available from: https://medicopublication.com/index.php/ijphrd/article/view/10232